Imunon
IMNN
37 hedge funds and large institutions have $8.54M invested in Imunon in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 7 closing their positions.
106% more call options, than puts
Call options by funds: $231K | Put options by funds: $112K
6% more capital inflows, than outflows
Capital inflows: $1.24M | Capital outflows: $1.17M
0.22% more ownership
Funds ownership: 10.46% → 10.67% (+0.22%)
0% more funds holding
Funds holding: 37 → 37 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$764K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$234K |
| 3 |
Two Sigma Advisers
New York
|
+$77.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$58.1K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$27.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$431K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$251K |
| 3 |
Millennium Management
New York
|
-$228K |
| 4 |
Two Sigma Investments
New York
|
-$63.5K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$63K |
IMNN Hedge Fund Activity: Q3 2021 in Review
37 of the 5,732 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q3 2021, worth a combined $8.54M — down 26% from $11.5M a quarter earlier.
Fund positioning in IMNN was balanced in Q3 2021: 7 funds opened new positions, 7 closed out, 7 added to existing stakes and 9 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $764K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $431K sold.
- 37 institutional investors held Imunon (IMNN) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $8.54M of Imunon stock for Q3 2021, down 26% quarter-over-quarter.
- 7 funds opened new Imunon positions in Q3 2021 and 7 closed out, a net change of 0 holders.
- The largest Imunon buyer in Q3 2021 was Morgan Stanley, an estimated $764K added.
- The largest Imunon seller in Q3 2021 was Renaissance Technologies, an estimated $431K sold.
Based on aggregated 13F filings for Q3 2021.